Chunsheng Kang mainly investigates Cancer research, Glioma, microRNA, Cell growth and Cell cycle. Chunsheng Kang has included themes like Apoptosis, Protein kinase B, Wnt signaling pathway, Oncogene and Regulation of gene expression in his Cancer research study. His Glioma study combines topics from a wide range of disciplines, such as Bioinformatics, Molecular biology, Gene silencing, Gene and PI3K/AKT/mTOR pathway.
His microRNA study combines topics in areas such as Carcinogenesis, Downregulation and upregulation, Messenger RNA and Signal transduction, Cell biology. The Cell growth study combines topics in areas such as Cell culture and Blot. His Cell cycle study incorporates themes from In vivo, Hox gene and Long non-coding RNA, HOTAIR.
His primary areas of study are Cancer research, Glioma, microRNA, Molecular biology and Cell growth. The concepts of his Cancer research study are interwoven with issues in Cell, Cell cycle, Oncogene, Protein kinase B and In vivo. His Glioma research is multidisciplinary, incorporating perspectives in Cell culture, Apoptosis, Catenin, Downregulation and upregulation and Signal transduction.
His work carried out in the field of microRNA brings together such families of science as Angiogenesis, Gene knockdown, Cell biology, Regulation of gene expression and Gene silencing. His Molecular biology study which covers Transfection that intersects with Genetic enhancement and Expression vector. His study in Cell growth is interdisciplinary in nature, drawing from both Notch signaling pathway and Antisense RNA.
The scientist’s investigation covers issues in Cancer research, CRISPR, Cell, In vivo and RNA. His study in Temozolomide and Glioma is carried out as part of his studies in Cancer research. His Cell study incorporates themes from Phosphorylcholine, Transcription factor and Cancer immunotherapy.
In general In vivo study, his work on Biodistribution often relates to the realm of Delivery system, thereby connecting several areas of interest. His work deals with themes such as Trans-activating crRNA and Computational biology, which intersect with RNA. In his research, microRNA is intimately related to Biogenesis, which falls under the overarching field of Computational biology.
His main research concerns Cancer research, Glioma, Cancer immunotherapy, In vivo and Cancer cell. His Cancer research study focuses on Temozolomide in particular. The study incorporates disciplines such as Tumor progression, Protein kinase B, Mutant and Gene knockdown in addition to Glioma.
His research in Cancer immunotherapy intersects with topics in Trans-activating crRNA, Cell, Chimeric antigen receptor and Tumor microenvironment. The In vivo study combines topics in areas such as Biophysics, Microglia and In situ polymerization. His Cancer cell research includes elements of Epithelial–mesenchymal transition, Metastasis, Paracrine signalling, Transactivation and HOTAIR.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
Xuan Zhou;Yu Ren;Lynette Marie Moore;Mei Mei.
Laboratory Investigation (2010)
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
Chun-Zhi Zhang;Jun-Xia Zhang;An-Ling Zhang;Zhen-Dong Shi.
Molecular Cancer (2010)
Non-coding RNAs as regulators in epigenetics (Review)
Jian-Wei Wei;Kai Huang;Chao Yang;Chun-Sheng Kang.
Oncology Reports (2017)
Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.
P Pu;Z Zhang;C Kang;R Jiang.
Cancer Gene Therapy (2009)
Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.
Jiang Chang;Youssef Jallouli;Maya Kroubi;Xu-bo Yuan.
International Journal of Pharmaceutics (2009)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang;Do-Hyun Nam;Zvi Ram;Wai-Sang Poon.
Cancer Letters (2016)
Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
Hongzhao Qi;Chaoyong Liu;Lixia Long;Yu Ren.
ACS Nano (2016)
MiRNA-451 plays a role as tumor suppressor in human glioma cells.
Yang Nan;Lei Han;Lei Han;Anling Zhang;Guangxiu Wang.
Brain Research (2010)
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Zhao Shi Bao;Hui Min Chen;Ming Yu Yang;Chuan Bao Zhang.
Genome Research (2014)
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
Yu Ren;Xuan Zhou;Mei Mei;Xu-Bo Yuan.
BMC Cancer (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: